Owner AstraZeneca AB

Inventors Andersson, Johan; Gyback, Helena; Johansson, Anh; Linde, Christian Erik; Malmstrom, Jonas; Nordvall, Gunnar; Terp, Gitte; Weigelt, Tatjana

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010266753

PCT Pub. Number WO2011/002405

Priority 61/221,657 30.06.09 US

Filing date 29 June 2010

Wipo publication date 6 January 2011

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/443 (2006.01)

A61K 31/444 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 307/82 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group